Abstract
A 47-year-old woman who underwent allogenic peripheral blood stem cell transplant developed withdrawal symptoms soon after Fentanyl 25 mcg/h patch was stopped, which has not been reported at this dose. Possible causes, such as the inhibition of CYP3A4 induced by cyclosporine causing elevations of serum fentanyl, are discussed. © 2006 American Academy of Pain Medicine.
Cite
CITATION STYLE
APA
Tsutsumi, Y., Kanamori, H., Tanaka, J., Asaka, M., Imamura, M., & Masauzi, N. (2006). Withdrawal symptoms from transdermal fentanyl (TDF) after an allogeneic peripheral blood stem cell transplant (PBSCT). Pain Medicine, 7(2), 164–165. https://doi.org/10.1111/j.1526-4637.2006.00107.x
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free